This document is an excerpt from the EUR-Lex website
Document 52003XC1128(01)
Summary of Community decisions on marketing authorisations in respect of medicinal products from 15 October 2003 to 15 November 2003 (Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93)
Summary of Community decisions on marketing authorisations in respect of medicinal products from 15 October 2003 to 15 November 2003 (Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93)
Summary of Community decisions on marketing authorisations in respect of medicinal products from 15 October 2003 to 15 November 2003 (Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93)
SL C 285, 28.11.2003, p. 2–6
(ES, DA, DE, EL, EN, FR, IT, NL, PT, FI, SV)
52003XC1128(01)
Summary of Community decisions on marketing authorisations in respect of medicinal products from 15 October 2003 to 15 November 2003 (Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93)
Official Journal C 285 , 28/11/2003 P. 0002 - 0006
Summary of Community decisions on marketing authorisations in respect of medicinal products from 15 October 2003 to 15 November 2003 (Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93(1)) (2003/C 285/02) - Issuing of a marketing authorisation (Article 12 of Regulation (EEC) No 2309/93): Accepted >TABLE> - Modification of a marketing authorisation (Article 12 of Regulation (EEC) No 2309/93): Accepted >TABLE> - Modification of a marketing authorisation (Article 12 of Regulation (EEC) No 2309/93): Rejected >TABLE> - Issuing of a marketing authorisation (Article 34 of Regulation (EEC) No 2309/93): Accepted >TABLE> - Modification of a marketing authorisation (Article 34 of Regulation (EEC) No 2309/93): Accepted >TABLE> Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact: The European Agency for the Evaluation of Medicinal products 7 Westferry Circus Canary Wharf London E14 4HB United Kingdom. (1) OJ L 214, 24.8.1993, p. 1.